Iqvia Holdings Inc (IQV) Stock Price, Quote & News

Company Profile

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 919 998 2000

Website: www.iqvia.com

Address:

2400 Ellis Road, Durham, United States

STRelativeStrength Sep. 7 at 4:35 PM

$IQV undiscovered breakout with 1229 watchers

0 · Reply

Stocktwits52wHighs Sep. 4 at 3:01 PM

$IQV printed a new 52-week high today

0 · Reply

Stocktwits52wHighs Sep. 2 at 7:31 PM

$IQV printed a new 52-week high today

0 · Reply

IN0V8 Sep. 1 at 4:39 PM

$IQV Buy HSBC raises target price to $300 from $280

0 · Reply

1manfund Aug. 31 at 4:00 AM

$IQV is the AI Transformation partner of choice for Biotech/Big Pharma "19 of the largest 20 pharmaceutical companies are using IQVIA's AI technology in their operations" I like this company

0 · Reply

Stocktwits52wHighs Aug. 26 at 4:01 PM

$IQV printed a new 52-week high today

0 · Reply

Stocktwits Aug. 24 at 5:34 PM

$IQV Only 1,200 watchers 👀

0 · Reply

Stocktwits52wHighs Aug. 24 at 5:31 PM

$IQV printed a new 52-week high today

0 · Reply

CapitalMonk Aug. 22 at 2:18 AM

$IQV Price: $259.82 (+1.47%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.78% RSI: 71.8 | Momentum: Strong Momentum Volume: -26.5% vs avg Volatility: 3.67% Support: $206.87 | Resistance: $260.40 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

Stocktwits52wHighs Aug. 20 at 7:01 PM

$IQV printed a new 52-week high today

0 · Reply

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

IQV

Aug 27, 2026, 4:15 PM EDT - 11 days ago

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

IQV

Aug 20, 2026, 4:15 PM EDT - 18 days ago

IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year

IQV

Aug 17, 2026, 4:15 PM EDT - 21 days ago

IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group

IQV

Aug 4, 2026, 4:15 PM EDT - 4 weeks ago

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

IQV

Jul 28, 2026, 12:44 PM EDT - 6 weeks ago

This Healthcare Stock Is Today's Best in the S&P 500

IQV

Jul 28, 2026, 9:02 AM EDT - 6 weeks ago

IQVIA raises annual profit forecast on clinical research demand

IQV

Jul 28, 2026, 9:00 AM EDT - 6 weeks ago

IQVIA Holdings Earnings Call Transcript: Q2 2026

Jul 28, 2026, 9:00 AM EDT - 6 weeks ago

IQVIA Holdings Earnings release: Q2 2026

Jul 28, 2026, 9:00 AM EDT - 6 weeks ago

IQVIA Holdings Slides: Q2 2026

Jul 28, 2026, 9:00 AM EDT - 6 weeks ago

IQVIA Holdings Quarterly report: Q2 2026

Jul 28, 2026, 7:00 AM EDT - 6 weeks ago

IQVIA Reports Second-Quarter 2026 Results

IQV

Jul 16, 2026, 1:39 PM EDT - 7 weeks ago

IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States

IQV

Jul 8, 2026, 4:15 PM EDT - 2 months ago

IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026

IQV

Jun 18, 2026, 10:17 AM EDT - 2 months ago

StackAdapt Teams Up with IQVIA Digital's MediaOS to Power Healthcare Advertising

IQV

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX

Jun 15, 2026, 9:00 AM EDT - 2 months ago

Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain

IQV WLY

Jun 4, 2026, 10:51 AM EDT - 3 months ago

IQVIA Announces Pricing of Senior Notes

IQV

Jun 3, 2026, 9:20 AM EDT - 3 months ago

IQVIA Holdings Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:53 AM EDT - 3 months ago

IQVIA Announces Offering of Senior Notes

IQV

May 26, 2026, 4:15 PM EDT - 3 months ago

IQVIA CEO to Speak at Jefferies Global Healthcare Conference

IQV

May 13, 2026, 4:30 PM EDT - 3 months ago

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

IQV

May 13, 2026, 1:40 PM EDT - 3 months ago

IQVIA Holdings Transcript: Bank of America Global Healthcare Conference 2026

May 7, 2026, 5:15 PM EDT - 4 months ago

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

IQV

May 6, 2026, 4:15 PM EDT - 4 months ago

IQVIA CFO to Speak at Bank of America Health Care Conference 2026

IQV

May 5, 2026, 9:00 AM EDT - 4 months ago

IQVIA Holdings Earnings Call Transcript: Q1 2026

May 5, 2026, 9:00 AM EDT - 4 months ago

IQVIA Holdings Earnings release: Q1 2026

May 5, 2026, 9:00 AM EDT - 4 months ago

IQVIA Holdings Slides: Q1 2026

May 5, 2026, 9:00 AM EDT - 4 months ago

IQVIA Holdings Quarterly report: Q1 2026

May 5, 2026, 7:00 AM EDT - 4 months ago

IQVIA Reports First-Quarter 2026 Results

IQV

Apr 15, 2026, 4:15 PM EDT - 4 months ago

IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

IQV

Mar 16, 2026, 4:30 PM EDT - 5 months ago

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

IQV

Mar 12, 2026, 9:30 AM EDT - 6 months ago

IQVIA Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 9, 2026, 9:20 AM EDT - 6 months ago

IQVIA Holdings Transcript: Leerink Global Healthcare Conference 2026

Mar 2, 2026, 4:30 PM EST - 6 months ago

IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference

IQV

Mar 2, 2026, 4:15 PM EST - 6 months ago

IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference

IQV

Feb 27, 2026, 4:47 PM EST - 6 months ago

IQVIA Releases its 2025 Sustainability Report

IQV

Feb 27, 2026, 7:00 AM EST - 6 months ago

IQVIA Holdings Proxy statement: Proxy Filing

Feb 27, 2026, 7:00 AM EST - 6 months ago

IQVIA Holdings Proxy statement: Proxy Filing

Feb 26, 2026, 11:00 AM EST - 6 months ago

IQVIA Holdings Transcript: Citi’s 2026 Unplugged MedTech and Life Sciences Access Day

Feb 25, 2026, 7:00 AM EST - 6 months ago

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

IQV

Feb 24, 2026, 9:01 AM EST - 6 months ago

10 stocks Wall Street expects to roar back after dropping at least 20% in 2026

APP BKNG COF CSGP IQV KKR NOW

Feb 18, 2026, 4:15 PM EST - 6 months ago

IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day

IQV

Feb 10, 2026, 8:00 AM EST - 7 months ago

IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

IQV

Feb 5, 2026, 9:07 AM EST - 7 months ago

IQVIA forecasts weak annual profit on higher interest expenses

IQV

Feb 5, 2026, 9:00 AM EST - 7 months ago

IQVIA Holdings Earnings Call Transcript: Q4 2025

Feb 5, 2026, 9:00 AM EST - 7 months ago

IQVIA Holdings Annual report: Q4 2025

Feb 5, 2026, 9:00 AM EST - 7 months ago

IQVIA Holdings Earnings release: Q4 2025

Feb 5, 2026, 9:00 AM EST - 7 months ago

IQVIA Holdings Slides: Q4 2025

Feb 5, 2026, 7:00 AM EST - 7 months ago

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

IQV

Jan 29, 2026, 8:00 AM EST - 7 months ago

IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

IQV

Jan 22, 2026, 4:05 PM EST - 7 months ago

IQVIA Named to the Fortune® World's Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year

IQV

Jan 20, 2026, 4:45 PM EST - 7 months ago

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

IQV

Dec 2, 2025, 8:00 AM EST - 9 months ago

IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

IQV

Nov 11, 2025, 12:30 PM EST - 10 months ago

IQVIA Holdings Transcript: UBS Global Healthcare Conference 2025

Nov 5, 2025, 4:15 PM EST - 10 months ago

Dr. William G. Kaelin Jr. joins IQVIA Board of Directors

IQV

Oct 28, 2025, 9:00 AM EDT - 10 months ago

IQVIA Holdings Earnings Call Transcript: Q3 2025

Oct 28, 2025, 9:00 AM EDT - 10 months ago

IQVIA Holdings Quarterly report: Q3 2025

Oct 28, 2025, 9:00 AM EDT - 10 months ago

IQVIA Holdings Earnings release: Q3 2025

Oct 28, 2025, 9:00 AM EDT - 10 months ago

IQVIA Holdings Slides: Q3 2025

Oct 28, 2025, 7:53 AM EDT - 10 months ago

IQVIA narrows annual profit forecast amid continued research contract cancellations

IQV

Oct 28, 2025, 7:00 AM EDT - 10 months ago

IQVIA Reports Third-Quarter 2025 Results

IQV

Oct 21, 2025, 4:15 PM EDT - 10 months ago

IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025

IQV

Sep 30, 2025, 4:15 PM EDT - 11 months ago

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

IQV

Sep 26, 2025, 9:40 AM EDT - 11 months ago

ILMN Stock vs. IQV Stock

ILMN IQV

Sep 16, 2025, 8:00 AM EDT - 11 months ago

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

IQV

Sep 10, 2025, 8:00 AM EDT - 12 months ago

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

IQV

Sep 2, 2025, 9:41 AM EDT - 1 year ago

IQVIA names Michael Fedock as financial chief

IQV

Sep 2, 2025, 9:00 AM EDT - 1 year ago

IQVIA Announces CFO Transition in Early 2026

IQV

Aug 28, 2025, 8:00 AM EDT - 1 year ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA SANA

Aug 19, 2025, 12:00 PM EDT - 1 year ago

The Big 3: BLDR, IQV, LOW

BLDR IQV LOW

Aug 18, 2025, 9:00 AM EDT - 1 year ago

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

IQV VEEV

Jul 22, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Earnings Call Transcript: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Quarterly report: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Earnings release: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Slides: Q2 2025

Jul 22, 2025, 8:42 AM EDT - 1 year ago

IQVIA beats quarterly estimates on resilient demand for healthcare analytics

IQV

Jul 22, 2025, 7:00 AM EDT - 1 year ago

IQVIA Reports Second-Quarter 2025 Results

IQV

STRelativeStrength Sep. 7 at 4:35 PM

$IQV undiscovered breakout with 1229 watchers

0 · Reply

Stocktwits52wHighs Sep. 4 at 3:01 PM

$IQV printed a new 52-week high today

0 · Reply

Stocktwits52wHighs Sep. 2 at 7:31 PM

$IQV printed a new 52-week high today

0 · Reply

IN0V8 Sep. 1 at 4:39 PM

$IQV Buy HSBC raises target price to $300 from $280

0 · Reply

1manfund Aug. 31 at 4:00 AM

$IQV is the AI Transformation partner of choice for Biotech/Big Pharma "19 of the largest 20 pharmaceutical companies are using IQVIA's AI technology in their operations" I like this company

0 · Reply

Stocktwits52wHighs Aug. 26 at 4:01 PM

$IQV printed a new 52-week high today

0 · Reply

Stocktwits Aug. 24 at 5:34 PM

$IQV Only 1,200 watchers 👀

0 · Reply

Stocktwits52wHighs Aug. 24 at 5:31 PM

$IQV printed a new 52-week high today

0 · Reply

CapitalMonk Aug. 22 at 2:18 AM

0 · Reply

Stocktwits52wHighs Aug. 20 at 7:01 PM

$IQV printed a new 52-week high today

0 · Reply

AcceleratorModel Aug. 20 at 4:07 PM

$IQV strong since earnings

0 · Reply

RuthNordquist295 Aug. 20 at 7:37 AM

$MSCI $IQV $IBKR $WAT $HMC MSCI benefits from investment indexes and analytics demand, IQVIA benefits from pharmaceutical research and clinical-trial activity, Interactive Brokers benefits from trading and client-asset growth, Waters benefits from analytical and laboratory equipment demand, and Honda benefits from global vehicle demand. I'm watching asset flows, clinical spending, trading volumes, lab demand, and auto sales.

0 · Reply

Sirsquiggleburp Aug. 11 at 7:49 PM

$IQV HMMMM, I spy with my little eye.

0 · Reply

TICKERTUTOR Aug. 10 at 2:52 PM

$TEM $CAI $IQV $NTRA https://venturebeat.com/orchestration/stanford-is-running-37-000-ai-agents-as-a-virtual-biotech-and-one-of-its-drug-designs-got-independently-confirmed-by-merck

0 · Reply

DeannaTaylor1000 Aug. 5 at 6:47 AM

$PCG $BIDU $PEG $STLD $IQV PG&E continues strengthening regulated utility operations, Baidu expands AI and cloud services, Public Service Enterprise Group provides dependable utility earnings, Steel Dynamics benefits from infrastructure demand, and IQVIA supports pharmaceutical research and development.

0 · Reply

IN0V8 Aug. 3 at 4:19 PM

$IQV Buy HSBC raises target price to $280 from $240

0 · Reply

KateBlack770 Aug. 3 at 2:45 PM

$COIN $NTRA $PEG $IQV $HMC Coinbase benefits from crypto adoption, Natera leads genetic testing, Public Service Enterprise Group provides regulated utility exposure, IQVIA supports pharmaceutical research, and Honda continues advancing hybrid and EV technologies.

0 · Reply

Tenet_Trading Jul. 29 at 7:33 PM

$IQV slept on ticket

0 · Reply

topstockalerts Jul. 28 at 8:07 PM

$IQV that breakout actually stuck

0 · Reply

AcceleratorModel Jul. 28 at 5:22 PM

$IQV nice

0 · Reply

HundredXQuest Jul. 28 at 4:34 PM

$IQV Hearing whispers that OZSC is bringing in a seasoned VP of International Sales to lead global expansion for their subsidiary lines. Dedicated sales leadership is going to transform the revenue baseline! 🔥🚀

0 · Reply

Trading_up_portfolio Jul. 28 at 4:19 PM

Made a bunch of changes to my portfolio today: - Closed the last of my $GOOG position from last year, rolling into LEAPS - closed out of $FIG Options for 50%. Still have shares and will add on dips. - closed $IQV position off of ER beat - decided to keep $OKLO the risk reward is worth - added $AMD for earnings 🪶🪶🪶

0 · Reply

Market Cap	44.07B
Revenue (ttm)	16.31B
Net Income (ttm)	1.36B
EPS (ttm)	N/A
PE Ratio	23.57
Forward PE	23.15
Profit Margin	8.34%
Debt to Equity Ratio	2.54

Volume	481,164
Avg Vol	1,377,860
Day's Range	N/A - N/A
Shares Out	164.60M
Stochastic %K	78%
Beta	1.18
Analysts	Strong Sell
Price Target	$273.50